All Pharma News
price-trendAsk Us
Lycia Completes $106.6M Series C For LYTAC Protein Degraders

Lycia Completes $106.6M Series C For LYTAC Protein Degraders
GLOBENEWSWIRE
13 May 2024
Share Share
Lycia Therapeutics to Present at Jefferies Healthcare Conference

Lycia Therapeutics to Present at Jefferies Healthcare Conference
PRESS RELEASE
13 May 2024
Share Share
Lycia Therapeutics to Present at Jefferies Healthcare Conference

Lycia Therapeutics to Present at Jefferies Healthcare Conference
GLOBENEWSWIRE
05 Jun 2023
Share Share
Lycia Therapeutics Founder Dr. Carolyn Bertozzi Awarded 2022 Nobel Prize

Lycia Therapeutics Founder Dr. Carolyn Bertozzi Awarded 2022 Nobel Prize
GLOBENEWSWIRE
05 Oct 2022
Share Share
Lycia Tx Appoints Steve Staben, Ph.D. as CSO

Lycia Tx Appoints Steve Staben, Ph.D. as CSO
GLOBENEWSWIRE
28 Feb 2022
Share Share
Lilly-backed Lycia Therapeutics nabs $70M round

Lilly-backed Lycia Therapeutics nabs $70M round
Ben Adams FIERCEBIOTECH
09 Sep 2021
Share Share
Lilly doubles down on protein degradation with $35M Lycia deal

Lilly doubles down on protein degradation with $35M Lycia deal

A. Al Idrus FIERCEBIOTECH
26 Aug 2021
Share Share